Resilience of a research center in the “Vacunagate”

Authors

DOI:

https://doi.org/10.36393/spmi.v35i3.685

Keywords:

SARS-Cov-2, COVID-19, vaccine, Sinopharm, Vacunagate

Abstract

The author, principal investigator of the Research Center of the Universidad Nacional Mayor de San Marcos, presents his point of view according to which his
center complied with the provisions of the Sinopharm vaccine protocol, maintaining an ethical and scientific integrity and, nevertheless, was immersed in the
notorious “Vacunagate” case.

Downloads

Download data is not yet available.

Downloads

Published

2022-08-29

Issue

Vol. 35 No. 3 (2022)

Section

Opinión

How to Cite

Resilience of a research center in the “Vacunagate”. (2022). Revista De La Sociedad Peruana De Medicina Interna, 35(3), e685. https://doi.org/10.36393/spmi.v35i3.685